Heron Therapeutics (HRTX) Resubmits NDA to FDA for HTX-011 for Treatment of Postoperative Pain

Go back to Heron Therapeutics (HRTX) Resubmits NDA to FDA for HTX-011 for Treatment of Postoperative Pain
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 13.85 -1.69 (10.88%)
Previous Close $15.54    52 Week High $31.32 
Open $15.84    52 Week Low $13.95 
Day High $15.89    P/E N/A 
Day Low $13.12    EPS $-3.29 
Volume 8,386,936